Skip to main content

Table 3 Treatment and clinical outcomes

From: Prognosis of liver abscess with no identified organism

 

CNLA (n = 156)

CPLA (n = 246)

Causative organism

P value

E.coli (n = 74)

K.pneumoniae (n = 133)

P value*

Other (n = 39)

Invasive procedure, n(%)

108 (69.2%)

195 (79.3%)

54 (73.0%)

108 (81.2%)

0.17

33 (84.6%)

0.02

Metastatic infection, n(%)

2 (1.3%)

12 (4.9%)

4 (5.4%)

7 (5.3%)

0.96

1 (2.6%)

0.05

In-hospital mortality, n(%)

6 (3.8%)

12 (4.9%)

5 (6.8%)

4 (3.0%)

0.20

3 (7.7%)

0.63

Length of hospital stay, days, median (IQR)

14.8 (7.75)

17.9 (8)

20 (15)

18 (9.5)

0.09

17 (16)

0.03

Recurrence, n (%)

12 (7.7%)

17 (6.9%)

6 (8.1%)

5 (3.8%)

0.18

6 (15.4%)

0.77

  1. *P value was calculated on two groups of E.coli liver abscess and K.pneumoniae liver abscess